From inside the an effective airplane pilot study, Sullivan and you may acquaintances (2013) evaluated employing endoscopic aspiration cures for treating obesity

From inside the an effective airplane pilot study, Sullivan and you may acquaintances (2013) evaluated employing endoscopic aspiration cures for treating obesity

AspireAssist Aspiration Therapy

This method entails endoscopic placement of a gastrostomy tube (A-Tube) and the AspireAssist siphon assembly (Aspire Bariatrics, King of Prussia, PA) to aspirate gastric contents 20 minutes after meal consumption. These researchers performed a study of 18 obese subjects who were randomly assigned (2:1) to groups that underwent aspiration therapy for 1 year plus lifestyle therapy (n = 11; mean BMI, 42.6 ± 1.4 kg/m(2)) or lifestyle therapy only (n = 7; mean BMI, 43.4 ± 2.0 kg/m(2)). Lifestyle intervention comprised a 15-session diet and behavioral education program; 10 of the 11 subjects who underwent aspiration therapy and 4 of the 7 subjects who underwent lifestyle therapy completed the 1st year of the study. After 1 year, subjects in the aspiration therapy group lost 18.6 % ± 2.3 % of their body weight (49.0 % ± 7.7 % of EWL) and those in the lifestyle therapy group lost 5.9 % ± 5.0 % (14.9 % ± 12.2 % of EWL) (p < 0.04); 7 of the 10 subjects in the aspiration therapy group completed an additional year of therapy and maintained a 20.1 % ± 3.5 % body weight loss (54.6 % ± 12.0 % of EWL). There were no AEs of aspiration therapy on eating behavior and no evidence of compensation for aspirated calories with increased food intake. No episodes of binge eating in the aspiration therapy group or serious AEs were reported. The authors concluded that aspiration therapy appeared to be a safe and effective long-term weight loss therapy for obesity. These preliminary findings from a pilot study need to be validated by well-designed studies.

Forssell and Noren (2015) evaluated the potency of a novel unit, the new AspireAssist ambition medication system, for treating obesity. Shortly after a month delivering an extremely-low-energy diet, twenty-five heavy men (Bmi 39.8 ± 0.nine kilogram/m(2)) encountered the AspireAssist gastrostomy tubing place during the good gastroscopy. A low-profile valve are installed 14 days afterwards and you can ambition away from gastric content material is did just as much as twenty minutes immediately after items 3 x for each day. Cognitive behavioural procedures has also been come. Within week six, indicate pounds lost is 16.5 ± 7.8 kilogram regarding the twenty two subjects exactly who completed twenty-six months of procedures (p = 0.001). The fresh new imply percentage EWL are 40.8 ± 19.8 % (p = 0.001); 2 sufferers was basically hospitalized to possess difficulties: step one topic for soreness shortly after gastrostomy tube location, that has been treated with analgesics, and one on account of a keen aseptic intra-intestinal water collection 24 hours after gastrostomy tube position. Zero medically tall changes in solution potassium or other electrolytes occurred. The newest experts figured in this studies, large diet is actually reached having couple difficulties utilising the AspireAssist program, suggesting its possible since the a stylish healing equipment to own heavy people.

Successful aspiration required thorough chew up away from drank dining

In a prospective observational study, Noren and Forssell (2016) evaluated the safety and effectiveness of the novel AspireAssist Aspiration Therapy System for treatment of obesity, and its effect on patient’s quality of life. A total of 25 obese subjects, mean age of 48 years (range of 33 to 65) were included in this study. A custom gastrostomy tube (A-tube) was percutaneously inserted during a gastroscopy performed under conscious sedation. Drainage and irrigation of the stomach were performed 3 times daily, 20 mins after each meal, for 1 to 2 years. Treatment included a cognitive behavioral weight loss program. Mean BMI at inclusion was 39.8 kg/m2 (range of 35 to 49). After 1 year mean (SD) BMI was 32.1 kg/m2 chodit s nÄ›kým swipe (5.4), p < 0.01, and EWL was 54.4 % (28.8), p < 0.01. Quality of life, as measured with EQ-5D, improved from 0.73 (0.27) to 0.88 (0.13), p < 0.01. After 2 years BMI was 31.0 kg/m2 (5.1), p < 0.01, and EWL was 61.5 % (28.5), p < 0.01. There were no serious AEs or electrolyte disorderspliance was 80 % after 1 year and 60 % after 2 years. The authors concluded that aspiration therapy is a safe and efficient treatment for obesity, and weight reduction improves quality of life. Excess weight was approximately halved in a year, with weight stability if treatment was continued; and long-term results remain to be investigated.

No Comments

Post A Comment